- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
News | Chuangyuan Biotechnology has been awarded the designation of 'Specialized, Refined, Characteristic, and Innovative' small and medium-sized enterprise by Tianjin.

Recently, the Tianjin Municipal Bureau of Industry and Information Technology announced the list of small and medium-sized enterprises (SMEs) to be recognized as 'Specialized, Refined, Characteristic, and Innovative' for the second batch of 2023. Tianjin Chuangyuan Biotechnology Co., Ltd. successfully passed the expert review and comprehensive evaluation due to its professional technical strength, innovative research and development capabilities, industry influence, and excellent corporate culture, and was awarded the recognition as a 'Specialized, Refined, Characteristic, and Innovative' SME in Tianjin.
'Specialized, Refined, Characteristic, and Innovative' is a major initiative implemented by the state to guide SMEs to follow a development path of 'specialization, refinement, characteristic, and innovation', enhance independent innovation capabilities and core competitiveness, and continuously improve the quality and level of SME development. According to Tianjin's recognition criteria, enterprises selected for the 'Specialized, Refined, Characteristic, and Innovative' SME list must achieve industry-leading levels in economic benefits, degree of specialization, innovation capabilities, and management operations.
This selection marks the authoritative recognition of Chuangyuan Biotechnology in aspects such as corporate credit, operational level, research and development strength, production capacity, digitalization level, management system construction, and independent brand innovation. At the same time, the company's leading products currently hold a high market share in domestic niche industries, playing an important role in 'breaking barriers, filling gaps, and addressing shortcomings'.
As a pioneering enterprise in the postbiotics industry, Chuangyuan Biotechnology will continue to refine its path of 'specialization, refinement, characteristic, and innovation' in the future, adhering to the corporate mission of 'Creating the Source of Life and Health, Making Life Healthier and More Wonderful!' It will strengthen technological innovation capabilities, enhance core competitiveness, empower industrial innovation, support intelligent manufacturing upgrades, and provide high-quality products, professional technology, and comprehensive solutions to serve the high-quality development of China's probiotics and postbiotics industry.

Related News